CD274 and nasopharyngeal carcinoma: NPC exhibits high levels of PD-L1 expression (over 90% of tumour cells) and abundant infiltration lymphocytes [12–14], suggesting that NPC patients may be potentially suitable for PD-1 blockade therapy.